Revenue

As Crane NXT readies for a key investor conference, its leadership will detail a strategy where trust, traceability, and tech converge to redefine global supply chains.

With sales down and its dividend cut, The Campbell's Company's new leadership faces a critical test at the upcoming Barclays investor conference.

Crescent Electric promotes Kristee Mitchell to Chief Supply Chain Officer, a strategic move to fortify its operations amid industry-wide disruption.

EQT's acquisition of McGill and Partners for $2 billion isn't just another deal. It's a high-stakes validation of a startup that rewrote the rules with tech and trust.

After a sharp stock drop, digital intelligence firm Cellebrite is betting on its advanced AI strategy to win back investors. Can it prove its growth story is real?

Folding bike leader DAHON TECH posts record profits, driven not just by sales, but by a deep strategy of proprietary patents, AI manufacturing, and ecosystem building.

Zscaler posts strong 25% growth, but a projected slowdown and heavy investment reveal a strategic pivot to dominate the security of the coming AI era.

With profits doubling and a massive cash infusion, Mama's Creations is executing a masterclass in growth. But can its operational engine keep pace?

As metal coatings giant AZZ Inc. embarks on a September investor roadshow, we look beyond the stock ticker to see what it reveals about our economy.

HARMAN’s appointment of software veteran Dr. Thomas Irawan signals a strategic shift from vision to execution in the race for the software-defined car.

Cipla and Qilu are teaming up to launch a biosimilar for Keytruda, the world's top cancer drug, signaling a major shift in patient access and market dynamics.

As AI answers replace search, most brand videos are invisible. Videowise's new tech makes authentic user content findable, helping brands build trust and value.

The medtech firm swung from a massive loss to a tiny profit by slashing costs and expanding in the U.S. But is this a sustainable turnaround or a risky gamble?

With a new cancer drug showing promise but cash reserves dwindling, Citius Pharma's CEO faces a critical test: convincing investors the pipeline is worth the risk.

TOYO Co., Ltd. is betting its future on controlling the entire solar supply chain. As its CSO meets investors, can this bold strategy navigate trade risks?

Amber International's bold pivot to specialized AI agents is already a financial success, with new 'agentic' revenue driving a return to profitability.

United Imaging's revolutionary dual wide-coverage CT scanners have gained European approval, promising to redefine diagnostics and challenge market leaders.

A top EV battery supplier just went public on the NYSE, but its real target is the AI boom. Can Londian Wason transform into a key player in NVIDIA's world?

Hello Group's Q2 earnings reveal a tale of two companies: a booming international segment masks a struggling core business in China. Is this global pivot a masterstroke or a desperate bet?

A late SEC filing and a prior 'going concern' warning reveal deep financial turmoil at the specialty coffee innovator, raising questions about its future.